Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Are Conventional Type 1 Dendritic Cells Critical for Protective Antitumor Immunity and How?
Jean-Charles Cancel, Karine Crozat, Marc Dalod, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 159

Showing 1-25 of 159 citing articles:

Single-cell analyses reveal key immune cell subsets associated with response to PD-L1 blockade in triple-negative breast cancer
Yuanyuan Zhang, Hongyan Chen, Hongnan Mo, et al.
Cancer Cell (2021) Vol. 39, Iss. 12, pp. 1578-1593.e8
Open Access | Times Cited: 489
cDC1 prime and are licensed by CD4+ T cells to induce anti-tumour immunity
Stephen T. Ferris, Vivek Durai, Renee Wu, et al.
Nature (2020) Vol. 584, Iss. 7822, pp. 624-629
Open Access | Times Cited: 423
Engineering dendritic cell vaccines to improve cancer immunotherapy
Caleb R. Perez, Michele De Palma
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 401
Immune Cell Membrane‐Coated Biomimetic Nanoparticles for Targeted Cancer Therapy
Fatemeh Oroojalian, M H Miran Beygi, Behzad Baradaran, et al.
Small (2021) Vol. 17, Iss. 12
Open Access | Times Cited: 351
Dendritic cell subsets and locations
Sreekumar Balan, Mansi Saxena, Nina Bhardwaj
International review of cell and molecular biology (2019), pp. 1-68
Closed Access | Times Cited: 270
COVID-19 severity associates with pulmonary redistribution of CD1c+ DCs and inflammatory transitional and nonclassical monocytes
Ildefonso Sánchez‐Cerrillo, Pedro Landete, Beatriz Aldave, et al.
Journal of Clinical Investigation (2020) Vol. 130, Iss. 12, pp. 6290-6300
Open Access | Times Cited: 179
Thermosensitive hydrogel releasing nitric oxide donor and anti-CTLA-4 micelles for anti-tumor immunotherapy
Jihoon Kim, David M. Francis, Lauren F. Sestito, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 107
Dendritic cells as orchestrators of anticancer immunity and immunotherapy
Ignacio Heras‐Murillo, Irene Adán‐Barrientos, Miguel Á. Galán, et al.
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 4, pp. 257-277
Closed Access | Times Cited: 105
CXCR3 expression in regulatory T cells drives interactions with type I dendritic cells in tumors to restrict CD8+ T cell antitumor immunity
Mariela A. Moreno Ayala, Timothy F. Campbell, Chen‐Yu Zhang, et al.
Immunity (2023) Vol. 56, Iss. 7, pp. 1613-1630.e5
Open Access | Times Cited: 103
Trial watch: Dendritic cell (DC)-based immunotherapy for cancer
Raquel S. Laureano, Jenny Sprooten, Isaure Vanmeerbeerk, et al.
OncoImmunology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 93
Lymphatic-preserving treatment sequencing with immune checkpoint inhibition unleashes cDC1-dependent antitumor immunity in HNSCC
Robert Saddawi‐Konefka, Aoife O’Farrell, Farhoud Faraji, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 91
An adjuvant strategy enabled by modulation of the physical properties of microbial ligands expands antigen immunogenicity
Francesco Borriello, Valentina Poli, Ellen Shrock, et al.
Cell (2022) Vol. 185, Iss. 4, pp. 614-629.e21
Open Access | Times Cited: 81
NK cells are never alone: crosstalk and communication in tumour microenvironments
Yongqiang Zhou, Cheng Lu, Lu Liu, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 81
Immune checkpoint blockade induces gut microbiota translocation that augments extraintestinal antitumor immunity
Yongbin Choi, Jake Lichterman, Laura Coughlin, et al.
Science Immunology (2023) Vol. 8, Iss. 81
Open Access | Times Cited: 67
Investigating the Dynamic Interplay Between Cellular Immunity and Tumor Cells in the Fight Against Cancer: An Updated Comprehensive Review
Seyed Ali Aghapour, Mehdi Torabizadeh, Seyed Sobhan Bahreiny, et al.
Iranian Journal of Blood and Cancer (2024) Vol. 16, Iss. 2, pp. 84-101
Closed Access | Times Cited: 32
cGAS-STING pathway mediates activation of dendritic cell sensing of immunogenic tumors
Guohao Li, Xiangqian Zhao, Zuda Zheng, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 19
Prostaglandin E2 in the Tumor Microenvironment, a Convoluted Affair Mediated by EP Receptors 2 and 4
Ana Santiso, Ákos Heinemann, Julia Kargl
Pharmacological Reviews (2024) Vol. 76, Iss. 3, pp. 388-413
Open Access | Times Cited: 16
The tumor microenvironment and dendritic cells: Developers of pioneering strategies in colorectal cancer immunotherapy?
Farid Ghorbaninezhad, Mina Afrashteh Nour, Omid Rahbar Farzam, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025) Vol. 1880, Iss. 2, pp. 189281-189281
Closed Access | Times Cited: 2
Trial watch: dendritic cell vaccination for cancer immunotherapy
Jenny Sprooten, Jolien Ceusters, An Coosemans, et al.
OncoImmunology (2019) Vol. 8, Iss. 11, pp. 1638212-1638212
Open Access | Times Cited: 134
The role of dendritic cells in cancer
Yoke Seng Lee, Kristen J. Radford
International review of cell and molecular biology (2019), pp. 123-178
Closed Access | Times Cited: 133
Transcriptional Networks Driving Dendritic Cell Differentiation and Function
Stephen L. Nutt, Michaël Chopin
Immunity (2020) Vol. 52, Iss. 6, pp. 942-956
Open Access | Times Cited: 125
Inflammasomes within Hyperactive Murine Dendritic Cells Stimulate Long-Lived T Cell-Mediated Anti-tumor Immunity
Dania Zhivaki, Francesco Borriello, Ohn A. Chow, et al.
Cell Reports (2020) Vol. 33, Iss. 7, pp. 108381-108381
Open Access | Times Cited: 122
Dexosomes as a cell-free vaccine for cancer immunotherapy
Sepideh Nikfarjam, Jafar Rezaie, Fatah Kashanchi, et al.
Journal of Experimental & Clinical Cancer Research (2020) Vol. 39, Iss. 1
Open Access | Times Cited: 105
Dendritic Cell Vaccines for Cancer Immunotherapy: The Role of Human Conventional Type 1 Dendritic Cells
João Calmeiro, Mylène A. Carrascal, Adriana Ramos Tavares, et al.
Pharmaceutics (2020) Vol. 12, Iss. 2, pp. 158-158
Open Access | Times Cited: 95
Advances in sepsis diagnosis and management: a paradigm shift towards nanotechnology
Amit Pant, Irene Mackraj, Thirumala Govender
Journal of Biomedical Science (2021) Vol. 28, Iss. 1
Open Access | Times Cited: 94
Page 1 - Next Page

Scroll to top